Look Under The Hood: PBE Has 22% Upside
November 17, 2020 at 08:07 AM EST
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Dynamic Biotechnology & Genome ETF (PBE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $76.10 per unit.